
Cellares and Cabaletta Bio Complete Rese-cel Manufacturing with Cell Shuttle™ Platform
Cellares and Cabaletta Bio Successfully Complete Technology Adoption Program for Rese-cel Using Cell Shuttle™ Platform Cellares, the first Integrated Development and Manufacturing Organization (IDMO), has successfully concluded the Technology Adoption Program (TAP) for its innovative automated cell therapy manufacturing platform,…












